Does irbesartan improve the risk of death or hospitalization for cardiovascular causes among patients with HF and PEF?
Lindenfeld
JoAnn
J
Cardiac Transplant Program, University of Colorado Health Sciences Center, 1635 Aurora Court, F749, Room 7083, Aurora, CO 80045, USA. joann.lindenfeld@ucdenver.edu